NCT02270567View on ClinicalTrials.gov

RegisterNET - A Registry for Neuroendocrine Tumors in the USA

Enrolling by invitationOBSERVATIONAL
Enrollment

400

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

March 31, 2018

Study Completion Date

December 31, 2025

Conditions
Neuroendocrine TumorCarcinoidNeuroendocrine Carcinoma
Interventions
DEVICE

NETest

Non-invasive blood test

Trial Locations (1)

06405

Wren Laboratories, Branford

All Listed Sponsors
lead

Wren Laboratories LLC

INDUSTRY